These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27432741)
1. Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis. Raby AC; Colmont CS; Kift-Morgan A; Köhl J; Eberl M; Fraser D; Topley N; Labéta MO J Am Soc Nephrol; 2017 Feb; 28(2):461-478. PubMed ID: 27432741 [TBL] [Abstract][Full Text] [Related]
2. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis. Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057 [TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells. Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989 [TBL] [Abstract][Full Text] [Related]
4. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells. Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188 [TBL] [Abstract][Full Text] [Related]
5. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. Raby AC; Le Bouder E; Colmont C; Davies J; Richards P; Coles B; George CH; Jones SA; Brennan P; Topley N; Labéta MO J Immunol; 2009 Jul; 183(1):506-17. PubMed ID: 19542461 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis. Singh K; Prasad KN; Mishra P; Khatoon J; Prasad N; Gupta A; Srivastava JK Int Urol Nephrol; 2015 Dec; 47(12):2031-7. PubMed ID: 26490558 [TBL] [Abstract][Full Text] [Related]
7. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2. Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). Wiersinga WJ; Wieland CW; Dessing MC; Chantratita N; Cheng AC; Limmathurotsakul D; Chierakul W; Leendertse M; Florquin S; de Vos AF; White N; Dondorp AM; Day NP; Peacock SJ; van der Poll T PLoS Med; 2007 Jul; 4(7):e248. PubMed ID: 17676990 [TBL] [Abstract][Full Text] [Related]
9. Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity. Raby AC; Labéta MO Front Physiol; 2018; 9():1692. PubMed ID: 30538643 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. Darville T; O'Neill JM; Andrews CW; Nagarajan UM; Stahl L; Ojcius DM J Immunol; 2003 Dec; 171(11):6187-97. PubMed ID: 14634135 [TBL] [Abstract][Full Text] [Related]
11. Benzenediamine analog FC-99 inhibits TLR2 and TLR4 signaling in peritoneal macrophage in vitro. Yang L; Dou H; Song Y; Hou Y Life Sci; 2016 Jan; 144():129-37. PubMed ID: 26620764 [TBL] [Abstract][Full Text] [Related]
12. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis. Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153 [TBL] [Abstract][Full Text] [Related]
13. Complement C5a receptors C5L2 and C5aR in renal fibrosis. Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945 [TBL] [Abstract][Full Text] [Related]
14. Elevated CD14 (Cluster of Differentiation 14) and Toll-Like Receptor (TLR) 4 Signaling Deteriorate Periapical Inflammation in TLR2 Deficient Mice. Rider D; Furusho H; Xu S; Trachtenberg AJ; Kuo WP; Hirai K; Susa M; Bahammam L; Stashenko P; Fujimura A; Sasaki H Anat Rec (Hoboken); 2016 Sep; 299(9):1281-92. PubMed ID: 27314637 [TBL] [Abstract][Full Text] [Related]
15. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Mandell L; Moran AP; Cocchiarella A; Houghton J; Taylor N; Fox JG; Wang TC; Kurt-Jones EA Infect Immun; 2004 Nov; 72(11):6446-54. PubMed ID: 15501775 [TBL] [Abstract][Full Text] [Related]
16. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Skerrett SJ; Wilson CB; Liggitt HD; Hajjar AM Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L312-22. PubMed ID: 16936244 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Okamoto M; Oh-E G; Oshikawa T; Furuichi S; Tano T; Ahmed SU; Akashi S; Miyake K; Takeuchi O; Akira S; Himeno K; Sato M; Ohkubo S Clin Diagn Lab Immunol; 2004 May; 11(3):483-95. PubMed ID: 15138173 [TBL] [Abstract][Full Text] [Related]
18. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Mirlashari MR; Lyberg T Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028 [TBL] [Abstract][Full Text] [Related]
19. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. Haase R; Kirschning CJ; Sing A; Schröttner P; Fukase K; Kusumoto S; Wagner H; Heesemann J; Ruckdeschel K J Immunol; 2003 Oct; 171(8):4294-303. PubMed ID: 14530354 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicles of Patients on Peritoneal Dialysis Inhibit the TGF-β- and PDGF-B-Mediated Fibrotic Processes. Szebeni B; Veres-Székely A; Pap D; Bokrossy P; Varga Z; Gaál A; Mihály J; Pállinger É; Takács IM; Pajtók C; Bernáth M; Reusz GS; Szabó AJ; Vannay Á Cells; 2024 Mar; 13(7):. PubMed ID: 38607044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]